A Study of IMMU-132 in Metastatic Urothelial Cancer after Failure of Platinum Based Regimen or Anti-PD-1/PD-L-1 Based Immunotherapy (18283)
A Study of IMMU-132 in Metastatic Urothelial Cancer after Failure of Platinum Based Regimen or Anti-PD-1/PD-L-1 Based Immunotherapy (18283)
Trial Category:
Genitourinary
Phase
II
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
